Abstract
Taurine is a β-amino acid found in very high concentration in excitable tissues [1]. Although the amino acid was discovered over 150 years ago, the only established role of taurine is conjugation with bile acids [1]. Yet, recent evidence has led to the view that taurine must have other physiological functions. One idea that has received considerable attention is that taurine serves as a stabilizer of biological membranes. This concept was originally proposed by Huxtable and Bressler [2], who showed that taurine protected sarcoplasmic reticulum from damage caused by either isolation of the membrane fraction or incubation of the membrane preparation with phospholipase C. Kramer et al. [3] provided further support for this hypothesis when they discovered that reduction in cellular damage resulting from the treatment of failing hearts with taurine was associated with an improvement in sarcolemmal function. Membrane stabilization has also been implicated in the ability of taurine to protect rod outer segments against light-induced lipid peroxidation [4], lymphoblastoid cells against iron-ascorbate-induced damage [5], and spermatozoa against loss of motility [6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Jacobsen JG, Smith LH Jr. 1968. Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48:424–511.
Huxtable R, Bressler R. 1973. Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta 323:573–583.
Kramer JH, Chovan JP, Schaffer SW. 1981. Effect of taurine on calcium paradox and ischemic heart failure. Am J Physiol 240:H238-H246.
Pasantes-Morales H, Cruz C. 1985. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res 330:154–157.
Pasantes-Morales H, Wright CE, Gaull GE. 1985. Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem Pharmacol 34:2205–2207.
Alvarez JG, Storey BT. 1983. Taurine hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol Reprod 29: 548–555.
Kulakowski EC, Maturo J, Schaffer SW. 1981. Solubilization and characterization of cardiac sarcolemmal taurine-binding proteins. Arch Biochem Biophys 210:204–209.
Sebring LA, Huxtable RJ. 1986. Low affinity binding of taurine to phospholiposomes and cardiac sarcolemma. Biochim Biophys Acta 884:559–566.
Chovan JP, Kulakowski EC, Benson BW, Schaffer SW. 1979. Taurine enhancement of calcium binding to rat heart sarcolemma. Biochim Biophys Acta 551:129–136.
Mozaffari MS, Tan BH, Lucia MA, Schaffer SW. 1986. Effect of drug-induced taurine depletion on cardiac contractility and metabolism. Biochem Pharmacol 35:985–989.
Garland PB, Shepherd D, Yates DW. 1965. Steady-state concentrations of coenzyme A, acetyl-coenzyme A and long-chain fatty acyl-coenzyme A in rat-liver mitochondria oxidizing palmitate. Biochem J 97:587–594.
Williamson JR, Corkey BE. 1969. Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods. Methods Enzymol 13:434–513.
Idell-Wenger JA, Grotyohann LW, Neely JR. 1978. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253:4310–4318.
McGarry JD, Foster DW. 1976. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 17:277–281.
Adams JD Jr, Lauterburg BH, Mitchell JR. 1983. Plasma glutathione and glutathione disulfide in the rat: Regulation and response to oxidative stress. J Pharmacol Exp Therap 227:749–754.
Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thio-barbituric acid reaction. Anal Biochem 95:351–358.
Alto LE, Dhalla NS. 1979. Myocardial cation contents during induction of calcium paradox. Am J Physiol 237:H713-H719.
Schaffer SW, Allo S, Mozaffari M. 1987. Potentiation of myocardial ischemic injury by drug-induced taurine depletion. In The biology of taurine: Methods and mechanisms, Huxtable RJ, Franconi F, Giotti A, eds. New York: Plenum Press, pp 151–158.
Katz AM, Messineo FC. 1981. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48:1–16.
Mak IT, Kramer JH, Weglicki WB. 1986. Potentiation of free radical-induced lipid peroxida-tive injury to sarcolemmal membranes by lipid amphiphiles. J Biol Chem 261:1153–1157.
Azuma J, Hamaguchi T, Ohta H, Takihara K, Awata N, Sawamura A, Harada H, Tanaka Y, Kishimoto S. 1987. Calcium overload-induced myocardial damage caused by isoproterenol and by adriamycin: Possible role of taurine in its prevention. In The biology of taurine: Methods and mechanisms, Huxtable R, Franconi F, Giotti A, eds. New York: Plenum Press, pp 167–179.
Hayes KC, Carey RE, Schmidt SY. 1975. Retinal degeneration associated with taurine deficiency in the cat. Science 188:949–951.
Hayes KC, Stephan ZF, Sturman JA. 1980. Growth depression in taurine-depleted infant monkeys. J Nutr 110:2058–2064.
Sturman JA, Moretz RC, French JH, Wisniewski HM. 1985. Taurine deficiency in the developing cat: Persistence of the cerebellar external granule cell layer. J Neurosci Res 13:405–416.
Sturman JA, Moretz RC, French JH, Wisniewski HM. 1985. Postnatal taurine deficiency in the kitten results in a persistence of the cerebellar external granule cell layer: Correction by taurine feeding. J Neurosci Res 13:521–528.
Pasantes-Morales H, Quesada O, Cárabez A, Huxtable RJ. 1983. Effects of the taurine transport antagonist, guanidinoethane sulfonate, and ß-alanine on the morphology of rat retina. J Neurosc Res 9:135–143.
Sawamura A, Sperelakis N, Azuma J, Kishimoto S. 1986. Effects of taurine on the electrical and mechanical activities of embryonic chick heart. Can J Physiol Pharmacol 64:649–655.
Welty MC, Welty JD, McBroom MJ. 1982. Effect of isoproterenol and taurine on heart calcium in normal and cardiomyopathic hamsters. J Mol Cell Cardiol 14:353–357.
Dhalla NS, Pierce GN, Panagia V, Singal PK, Beamish RE. 1982. Calcium movements in relation to heart function. Basic Res Cardiol 77:117–139.
Neely JR, Rovetto MJ, Oram JF. 1972. Myocardial utilization of carbohydrate and lipids. Prog Cardiovas Dis 15:289–329.
Lamers JMJ, Stinis HT, Montfoort A, Hülsmann WC. 1984. The effect of lipid intermediates on Ca2+ and Na+ permeability and (Na+ + K+)-ATPase of cardiac sarcolemma. Biochim Biophys Acta 774:127–137.
Adams RJ, Cohen DW, Gupte S, Johnson JD, Wallick ET, Wang T, Schwartz A. 1979. In vitro effects of palmitylcarnitine on cardiac plasma membrane Na,K-ATPase, and sarcoplasmic reticulum Ca2+-ATPase and Ca2+ transport. J Biol Chem 254:12404–12410.
Inoue D, Pappano AJ. 1983. L-Palmitylcarnitine and calcium ions act similarly on excitatory ionic currents in avian ventricular muscle. Circ Res 52:625–634.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Boston/Dordrecht/London
About this chapter
Cite this chapter
Schaffer, S.W., Allo, S., Harada, H., Stroo, W., Azuma, J., Hamaguchi, T. (1989). Mechanism Underlying the Membrane-Stabilizing Activity of Taurine. In: Iwata, H., Lombardini, J.B., Segawa, T. (eds) Taurine and the Heart. Developments in Cardiovascular Medicine, vol 93. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1647-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1647-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8915-9
Online ISBN: 978-1-4613-1647-3
eBook Packages: Springer Book Archive